🔎 Trials Near Me

Home › Rhabdomyosarcoma › Pennsylvania

Rhabdomyosarcoma clinical trials in Pennsylvania

4 studies for Rhabdomyosarcoma are looking for participants at sites in Pennsylvania.

Cities in Pennsylvania

Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors

  • Penn State Milton S. Hershey Medical Center and Children's Hospital, Hershey
RecruitingPhase 1/2
Up to age 30 · All sexes · Updated Nov 12, 2026 · NCT06541262

Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors

  • The Children's Hospital of Philadelphia (CHOP), Philadelphia
RecruitingPhase 1
24 Months – 18 Years · All sexes · Updated Oct 27, 2026 · NCT06441331

PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors

  • Children's Hospital of Philadelphia, Philadelphia
RecruitingPhase 1/2
Ages 1 to 30 · All sexes · Updated Oct 6, 2026 · NCT06721689

A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)

  • Lehigh Valley Hospital-Cedar Crest, Allentown
  • Children's Hospital of Philadelphia, Philadelphia
  • Saint Christopher's Hospital for Children, Philadelphia
  • and 1 more
RecruitingPhase 3
Up to age 50 · All sexes · Updated Aug 25, 2026 · NCT07466316

From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.